A detailed history of Worldquant Millennium Advisors LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Worldquant Millennium Advisors LLC holds 158,485 shares of NBIX stock, worth $19.9 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
158,485
Previous 69,461 128.16%
Holding current value
$19.9 Million
Previous $9.58 Million 127.75%
% of portfolio
0.2%
Previous 0.12%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$130.86 - $143.19 $11.6 Million - $12.7 Million
89,024 Added 128.16%
158,485 $21.8 Million
Q1 2024

May 15, 2024

BUY
$130.4 - $143.74 $6.62 Million - $7.3 Million
50,766 Added 271.55%
69,461 $9.58 Million
Q4 2023

Feb 14, 2024

SELL
$106.07 - $132.76 $321,498 - $402,395
-3,031 Reduced 13.95%
18,695 $2.46 Million
Q3 2023

Nov 14, 2023

SELL
$94.02 - $117.1 $9.16 Million - $11.4 Million
-97,430 Reduced 81.77%
21,726 $2.44 Million
Q2 2023

Aug 14, 2023

SELL
$89.53 - $104.87 $13.4 Million - $15.6 Million
-149,155 Reduced 55.59%
119,156 $11.2 Million
Q1 2023

May 15, 2023

BUY
$94.11 - $123.02 $1.62 Million - $2.12 Million
17,239 Added 6.87%
268,311 $27.2 Million
Q4 2022

Feb 14, 2023

BUY
$106.72 - $127.06 $17.1 Million - $20.4 Million
160,466 Added 177.1%
251,072 $30 Million
Q3 2022

Nov 14, 2022

BUY
$92.03 - $107.81 $8.34 Million - $9.77 Million
90,606 New
90,606 $9.62 Million
Q3 2020

Nov 16, 2020

SELL
$96.16 - $135.15 $9.9 Million - $13.9 Million
-103,004 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$85.09 - $130.36 $2.62 Million - $4.01 Million
-30,740 Reduced 22.98%
103,004 $12.6 Million
Q1 2020

May 14, 2020

BUY
$75.11 - $113.76 $9.63 Million - $14.6 Million
128,234 Added 2327.3%
133,744 $11.6 Million
Q4 2019

Feb 14, 2020

BUY
$86.8 - $118.57 $478,268 - $653,320
5,510 New
5,510 $592,000

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $12B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Worldquant Millennium Advisors LLC Portfolio

Follow Worldquant Millennium Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Worldquant Millennium Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Worldquant Millennium Advisors LLC with notifications on news.